Ricki
McCarroll

Culture Eats Strategy for Lunch Every Day

January 20th, 2012

…culture eats strategy for lunch every day. Now isn’t that the truth? Especially in PR where we put our logical strategic plans up to bat with popular culture daily and hope/wish our audiences hear and pay attention to our message.

Last week I had the pleasure and honor to attend the Health Affairs journal release event at the Capitol Hill Hyatt. This month’s journal was completely based around the #Diabetes pandemic in the United States and internationally with noted scholars such as Dr. Richard Kahn and K.M. Venkat Narayan.

My top take-a-ways:

Top three concepts:

  • Start looking at health from a wellness and prevention standpoint instead of looking at health through the lens of disease and illness
  • There is a need for community programs to combat pre-diabetes
  • Recognize a dual approach needed to combat diabetes – lifestyle and medications.

Top three quotes (who says researchers aren’t pithy?):

  • “Culture Eats Strategy for Lunch Every Day”
  • “Lack of social support is as lethal as cigarette smoking”
  • “WIIFM = What’s In It for Me”

The keynote speaker, Surgeon General Regina Benjamin, shared her take on health care in the U.S. and said we need to put the fun back into our health care. Her speech set the bar high for the remainder of the day as panelists began their presentations.

One panel in particular raised many questions and discussion about ‘The Potential for Lifestyle Changes and Weight Loss.’ The three panelists, Kenneth Thorpe, Richard Kahn and Mohammed K. Ali (not to be confused with the former boxer, Muhammad Ali) first presented their respective papers and then fielded questions from a very engaged audience. With the short presentations by Kenneth Thorpe and Mohammed Ali both individuals covered the results from the National Diabetes Prevention Program with positive language. Dr. Kahn threw some proverbial ‘cold water in the hot tub’ (his words) by reminding the audience to take the results with a grain of salt.

Read the rest of this entry »

Tags: ,

 
Kaitlin
Doody

How to Land a PR Internship (and Take Advantage Once You Do)

January 9th, 2012

Spectrum’s new crop of interns starts today! (Can you tell how excited us junior level staff are?!)

Summer 2011 interns present their final project to staff

This time of year reminds me of when I first started working at Spectrum as an intern in the spring of my senior year in college. In some ways, I feel like I was more buttoned up with my PR know-how then. I had mastered Grunig and Hunt’s four models of public relations and I could outline an RPIE approach to a campaign in no time. However, after being out in the “real world” for a few years now, I know that PR cannot be so easily defined or broken down into four simple models, and I’ve seen that there’s never as much time as we’d like to R (research), P (plan) and E (evaluate) – which is unfortunate, really.

Securing a PR internship and capitalizing on the opportunity is one of the most important things PR students need to do to land a job after college.  It’s the time when you begin to learn those invaluable out-of-the-classroom lessons. Below is a list of ways for students to distinguish themselves from other internship candidates and leave an impression (a good one, that is):

 

Read the rest of this entry »

Tags: , , ,

 
Luke
Dickinson

Why I like the FDA’s New Draft Guidelines

January 5th, 2012

The FDA released draft guidance last week which should prove helpful to pharmaceutical manufacturers, marketers and communicators. The draft guidance, Unsolicited Requests for Off-Label Information about Prescription Drugs and Medical Devices, addresses questions received by consumers around off-label drug or medical device use. It makes clear that manufacturers are able to provide information to requests on off-label uses, received both on- and off-line, without falling foul of regulations.

The draft guidelines allows for companies to respond to unsolicited requests for information on off-label use that are posted by consumers on public forums – including social media, websites, online forums, and in-person public events and meetings – as well as questions received in a non-public medium – via direct email, letter, phone call or fax. The key is that these must not be solicited questions, defined as any inquiry which results from one of eight possible scenarios or prompts led by the manufacturer.

The FDA advises that any response made to an unsolicited question must a) be made directly to the individual posing the question, and b) must only address the specific questions posed.

This means that even if an individual posts a question on off-label use to a company’s public Facebook wall, the company can only respond directly to that individual (via email, phone or letter) not publically to the post. The most that can be posted publically is information on how an individual can directly contact the company to have their specific question privately addressed.

Read the rest of this entry »

Tags: , , , , ,

 
Anthony
LaFauce

Why I dis-like the FDA’s New Draft Guidelines

January 5th, 2012

After reading the FDA’s ‘guidance’ I really have to say I am not impressed with this effort. To be honest it looks like a cookie cutter response to questions our industry has had for the past 4 years. I am truly moved by the fact the FDA opened with a disclaimer stating that the guidance provided was not the end-all-be-all to help communicators communicate.

FDA’s guidance documents, including this draft guidance, do not establish legally enforceable rights or responsibilities.

The document has some difficult to digest information regarding the difference between “non-public” and “public”. This means that the document fails to address if information is shared with a patient in a non-public area and that information becomes public. This is very disturbing if you consider the FDA’s guidance that information should be pushed to off label users in ‘private’ communication tools.

The document also has a small example, in line 189, which focuses on how information of a medical nature is presented to potential patients while on a website. The guidance suggests if a website talks about a various disease or condition AND includes items located in a header or menu that a refers to another disease condition a person can misconstrue this as a company endorsing a products use and the company is at fault.

If a firm sets up a website that enables viewers to read prepared standard responses for the firm’s products that are generated from prefixed pull-down menus naming various disease states, including any standard responses related to off-label uses for the firm’s product, resulting requests for off-label information would be considered solicited. Moreover, if this website makes it possible to use search terms to generate standard responses that go beyond the scope of the product information being requested, including off-label use information, resulting requests for and responses to such a search would be considered solicited requests.

Read the rest of this entry »

Tags: , , , , ,

 
Kelly
Barrett

Spectrum Celebrates 15 Years

December 23rd, 2011

Photo Credit: Scott Davis

Tis the season to celebrate, and celebrate Spectrum did, at our holiday party last Thursday, December 15. The Spectrum gang has a lot to celebrate this year, including 15 years of outstanding health and life science communications. Founder and CEOJohn Seng, what a milestone!

Read the rest of this entry »

Tags: , , ,

 
Luke
Dickinson

Decision 2012 – Presidential Candidates on Health Care

December 20th, 2011

Across early primary states Republican Presidential candidates are fighting tooth and nail to appeal to voters in the hope of becoming the next President of the United States of America.

While prime-time pundits may revel in polling data, “zany” tactics or the latest campaign trail gaffe, serious voters remain concerned with the issues. The economy has become the hot topic for the cycle, but with Democrat-led health care reforms still riling many Republicans, voters are paying close attention to the candidates’ stance on health care.

The overarching message from each and every candidate is dire need to “repeal Obamacare.” Republicans argue that “Obamacare,” the Affordable Care Act passed by President Obama in March of 2010, does little to improve health care quality while simultaneously restricting individual freedoms through requirements to purchase health insurance. If elected, each major Republican candidate would repeal “Obamacare.” But where will each candidate go from there?

Read the rest of this entry »

Tags: , , , ,